眼眶MRI联合颅内视觉通路扩散峰度成像诊断甲状腺相关眼病性视神经病变
回顾性纳入61例甲状腺相关眼病(TAO)患者(DON组25例40眼,非DON组36例72眼),测量眼眶MRI参数及颅内视觉通路DKI参数。联合眼眶MRI与颅内视觉通路DKI模型的诊断效能最佳(AUC=0.926),敏感度80%、特异度94.4%。
要点
- DON组眼眶MRI示眼外肌心尖部MI、AI及视神经SIR升高,视神经ADC降低。
- DON组颅内视觉通路DKI示视束、视辐射及BA17-19的KFA降低,视束及视辐射MK降低。
- 联合眼眶MRI与颅内视觉通路DKI参数诊断DON的AUC为0.926,敏感度80%、特异度94.4%。
核心结论
- 眼眶MRI和颅内视觉通路DKI均可辅助诊断DON,联合两者参数可进一步优化诊断效能。
研究设计与样本
- 回顾性纳入61例TAO患者(DON组25例40眼,非DON组36例72眼),测量眼眶MRI及颅内视觉通路DKI参数。
关键影像表现/征象
- DON组眼眶MRI示心尖部MI、心尖部AI及视神经SIR显著高于非DON组,视神经ADC显著低于非DON组(p<0.05)。
- DON组视束、视辐射及BA17、BA18、BA19的KFA显著低于非DON组,视束及视辐射的MK显著低于非DON组(p<0.05)。
诊断标准与关键数值
- 联合眼眶MRI与颅内视觉通路DKI参数模型诊断DON的AUC=0.926,敏感度80%、特异度94.4%。
- 眼眶MRI参数联合模型诊断DON的AUC=0.890。
- 颅内视觉通路DKI参数联合模型诊断DON的AUC=0.832。
临床应用与阅片要点
- 眼眶MRI可评估眼外肌心尖部指数、视神经直径指数、面积指数、ADC及信号强度比。
- 颅内视觉通路DKI可评估视束、视辐射及BA17-19的KFA和MK。
- 联合眼眶与颅内影像参数可优化DON诊断效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the combined performance of orbital MRI and intracranial visual pathway diffusion kurtosis imaging (DKI) in diagnosing dysthyroid optic neuropathy (DON).
METHODS: We retrospectively enrolled 61 thyroid-associated ophthalmopathy (TAO) patients, including 25 with DON (40 eyes) and 36 without DON (72 eyes). Orbital MRI-based apical muscle index (MI), diameter index (DI) of the optic nerve (ON), area index (AI) of the ON, apparent diffusion coefficient (ADC) and signal intensity ratio (SIR) of the ON, DKI-based kurtosis fractional anisotropy (KFA) and mean kurtosis (MK) of the optic tract (OT), optic radiation (OR), and Brodmann areas (BAs) 17, 18, and 19 were measured and compared between groups. The diagnostic performances of models were evaluated using receiver operating characteristic curve analyses and compared using the DeLong test.
RESULTS: TAO patients with DON had significantly higher apical MI, apical AI, and SIR of the ON, but significantly lower ADC of the ON than those without DON (p < 0.05). Meanwhile, the DON group exhibited significantly lower KFA across the OT, OR, BA17, BA18, and BA19 and lower MK at the OT and OR than the non-DON group (p < 0.05). The model integrating orbital MRI and intracranial visual pathway DKI parameters performed the best in diagnosing DON (AUC = 0.926), with optimal diagnostic sensitivity (80%) and specificity (94.4%), followed by orbital MRI combination (AUC = 0.890), and then intracranial visual pathway DKI combination (AUC = 0.832).
CONCLUSION: Orbital MRI and intracranial visual pathway DKI can both assist in diagnosing DON. Combining orbital and intracranial imaging parameters could further optimize diagnostic efficiency.
CLINICAL RELEVANCE STATEMENT: The novel finding could bring novel insights into the precise diagnosis and treatment of dysthyroid optic neuropathy, accordingly, contributing to the improvement of the patients' prognosis and quality of life in the future.
KEY POINTS: • Orbital MRI and intracranial visual pathway diffusion kurtosis imaging can both assist in diagnosing dysthyroid optic neuropathy. • Combining orbital MRI and intracranial visual pathway diffusion kurtosis imaging optimized the diagnostic efficiency of dysthyroid optic neuropathy.
引用
- Hu H, Zhou J, Jiang WH, et al. Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging. Eur Radiol. 2024. PMID: 38276980. doi:10.1007/s00330-024-10615-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。